This ticker has not been starred yet RMTI Rockwell Medical, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.62
Leverage 44.96%
Market Cap $ 52.7m
PE 0.00
Dividend Yield 0.00%
Profit $ -464.1k
Margin -0.46%

Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.

Subscribe Now For Access - Only $1.99 Per Month